Abstract
BackgroundCardiac amyloidosis is a systemic disease characterized by the deposition of misfolded proteins in the myocardium, which can lead to progressive impairment of cardiac function. Bone scintigraphy using technetium-99m-labeled tracers has become the established method for diagnosing transthyretin amyloidosis (ATTR). While diagnosis in clinical practice is primarily based on the visual Perugini score, the semi-quantitative analysis of SPECT/CT data sets is becoming increasingly important. The aim of this study was to investigate whether the calculation of quantitative parameters of Tc-99m-DPD uptake in the left ventricle are suitable for assessing the severity of cardiac amyloidosis.
Methods
A retrospective data analysis included 133 patients (m: n=83, f: n=50) with suspected cardiac amyloidosis. Using the Syngo.via software, regions of interest were delineated in the left ventricle and in reference regions (blood pool and erector spinae muscle), and SUV values were calculated. The relationship between the semi-quantitative parameters and the Perugini score was examined using Spearman’s correlation and linear regression. Statistical analysis was performed using JASP software (version 0.96).
Results
Of the 133 patients included in this retrospective study, 57 had a scintigraphically positive finding and 76 had a negative finding. Significant positive correlations were observed between the measured semi-quantitative SPECT/CT parameters and the Perugini score. The strongest correlation was observed for the left ventricular SUVbw(max). The LV/BP and LV/MU ratios also correlated significantly with the visual severity of the disease.
Conclusion
The results show that the measured semi-quantitative SPECT/CT parameters correlate closely with the Perugini score. In particular, the left ventricular SUVbw(max) proved to be a suitable parameter for the objective quantification of myocardial tracer uptake. Quantitative methods could improve the diagnosis and monitoring of cardiac amyloidosis in the future. However, prospective studies with larger patient cohorts are required to further establish these methods.
| Date of Award | 2026 |
|---|---|
| Original language | German (Austria) |
| Awarding Institution |
|
| Supervisor | Julia Pilz (Supervisor) & Dominik Wurm (Supervisor) |
Studyprogram
- Applied Technologies for Medical Diagnostics
Cite this
- Standard